Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Uninfected Adults
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Geoffrey J. Gorse, MD
St. Louis University
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Gaborone Prevention/treatment Trials Crs
Gaborone, Botswana
- Brigham and Women'S Hosp. Crs
Boston, Massachusetts, United States
- Fenway Community Health Clinical Research Site (fchcrs)
Boston, Massachusetts, United States
- Saint Louis Univ. School of Medicine, Hvtu
St Louis, Missouri, United States
- Miriam Hospital'S Hvtu
Providence, Rhode Island, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- —
- Primary completion
- —
- Completion
- 30 Sept 2005
- Last update posted
- 14 Oct 2021
- Registered enrollment
- 42
- Registry id
- NCT00054860
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.